Research ArticleClinical Studies
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS and ANDERS R. HOLMBERG
Anticancer Research December 2016, 36 (12) 6499-6504;
CAMILLA THELLENBERG-KARLSSON
3Norrlands University Hospital, Umeå, Sweden
CLAES NYMAN
2Stockholm South General Hospital, Stockholm, Sweden
STEN NILSSON
1Karolinska Institute, CCK/R8/00, Stockholm, Sweden
RENÉ BLOM
4Skånes University Hospital, Lund, Sweden
MARCELA MÁRQUEZ
1Karolinska Institute, CCK/R8/00, Stockholm, Sweden
ENRIQUE CASTELLANOS
1Karolinska Institute, CCK/R8/00, Stockholm, Sweden
ANDERS R. HOLMBERG
1Karolinska Institute, CCK/R8/00, Stockholm, Sweden
In this issue
Anticancer Research
Vol. 36, Issue 12
December 2016
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS, ANDERS R. HOLMBERG
Anticancer Research Dec 2016, 36 (12) 6499-6504;
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS, ANDERS R. HOLMBERG
Anticancer Research Dec 2016, 36 (12) 6499-6504;
Jump to section
Related Articles
- No related articles found.